26.09.2022

Rockley Photonics Unveils Next-Generation, Higher-Density Laser Spectrophotometer Chip for Wearable Health Monitoring

IPIC Industry partner, Rockley Photonics, have gone live with the below Press Release sharing details of their development of what is believed to be the world’s first micro-transfer-printed (mTP) silicon-photonics-based laser for commercial applications.’   Aaron Zilkie (CTO Rockley Photonics) commented on some particular fruits of engagement with IPIC referencing the ‘development of mTP lasers, work which started with Brian Corbett’s groupand the pitch shrink – innovation from Frank Peters, which impacts miniaturizing the size of and increasing the density of our laser arrays.’

This groundbreaking achievement is expected to allow Rockley to further increase the density and reduce the size of its high-density spectrophotometer chips — which are already the world’s smallest for broadband infrared wavelength laser spectrometry (covering 1000 nanometers of spectrum) and are smaller in area than LEDbased solutions currently used in wearables.

This advancement could potentially have a significant impact across a wide range of applications, including the design of exceptionally small wearable devices for the detection and measurement of multiple biomarkers. New silicon-photonics-based biosensing chips using mTP technology are expected to be available in the first half of 2024. The new chip technology should have no impact on the upcoming launch of Rockley’s Bioptx™ biosensing band nor on any current-generation products that Rockley and its customers are developing.

With this breakthrough in the mTP of silicon-photonics-based lasers, Rockley has dramatically increased the laser density of its photonics integrated circuits (PICs) for biosensing, creating what it believes to be the world’s highest-density broad-wavelength laser spectrophotometer chip, surpassing its own previous achievements. Moreover, the mTP process is expected to reduce  manufacturing costs and enable thinner, smaller footprint and higher-density chip designs. These attributes are powerful benefits for use in consumer and medtech devices and could facilitate the integration of Rockley’s biosensing technology into future tiny wearables.

Leveraging the mTP process, the new PIC technology will integrate a laser-generating “membrane” with a thickness of only 4 microns. The potential applications for this higherdensity and smaller-footprint chip technology extend beyond biosensing and health monitoring into other areas, such as ultra-small wearables, clothing, or XR/VR/AR headsets and glasses.

This mTP breakthrough is the direct result of Rockley’s multi-year partnership with the Tyndall National Institute at University College Cork in Ireland, X-Celeprint Limited, and the Irish Photonics Integration Centre (IPIC), with funding support from the Irish government’s Science Foundation Ireland (SFI) and Disruptive Technologies Innovation Fund (DTIF). The project started five years ago with a focus on developing a custom mTP process for Rockley’s silicon photonics platform and has involved a multidisciplinary team of world-class engineers and researchers. This technology, along with many other Rockley innovations, is backed by a robust multidisciplinary patent portfolio of over 200 issued patents and 295 pending patents in total.’

“Applying the micro-transfer printing process to the production of integrated lasers is a huge breakthrough that we believe will have a tremendous impact on wearable biosensing and on the photonics industry as a whole,” said Dr. Andrew Rickman, chairman and chief executive officer of Rockley. “We arguably have some of the most sophisticated photonics technology in the world, and this unprecedented level of miniaturization raises the bar even further. By creating biosensing chips that are smaller, lower-cost, and more efficient, we can continually improve our wearable biosensing products and deliver novel, relevant, and more powerful ways to monitor our health.”

“I believe that this next-gen, heterogeneous integration platform will lead to several significant technological advancements, including higher densities of lasers, increasingly smaller chip sizes, and ultra-high-volume manufacturing,” said Aaron Zilkie, chief technology officer of photonics at Rockley. “The team has been working on this project for years, and we are extremely excited to have reached this important milestone. We are grateful for the close collaboration we’ve had with our research partners and for the funding support from the Irish government and its Science Foundation Ireland and Disruptive Technologies Innovation Fund.”

For further information on Rockley Photonics see rockleyphotonics.com

18.09.2020

Launch of IPIC spinout company BioPixS

UCC Innovation has announced the launch of BioPixS, the latest spinout collaboration between IPIC SFI Research Centre, Tyndall National Institute, and UCC Innovation. BioPixS’ vision is to translate cutting-edge research into hi-tech, innovative solutions to impact the BioPhotonics market. Biophotonics is a multidisciplinary research area that focusses on the application of light-based technologies to life sciences and medicine. The BioPixS mission is to create standards in the field of Biophotonics through phantoms that simulate light interaction in scattering media like human tissue. BioPixS’ products will reduce the cost and time needed to develop hi-tech biomedical devices in photonics. On a social front, BioPixS’ phantoms target to reduce the animals used in preclinical trials by providing parallel solutions and optimise clinical trials, promoting a better world for our future generations.

For more information please see article